S
LJPC

SignatureFD’s La Jolla Pharmaceutical Company LJPC Stock Holding History

SignatureFD’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,000
Closed -$40K – 3388
2021
Q3 		$40K Hold
10,000
– – ﹤0.01% 1433
2021
Q2 		$43K Hold
10,000
– – ﹤0.01% 1355
2021
Q1 		$42K Hold
10,000
– – ﹤0.01% 1254
2020
Q4 		$39K Sell
10,000
-12,000
-55% -$51.3K ﹤0.01% 1196
2020
Q3 		$89K Hold
22,000
– – ﹤0.01% 750
2020
Q2 		$94K Buy
+22,000
New +$134K 0.01% 716

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SignatureFD's LJPC Position: Q4 2021 in Review

SignatureFD sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2021, closing a stake of 10,000 shares — an estimated $40K sold.

SignatureFD first reported a position in LJPC in Q2 2020 and held it in 6 quarters. The position peaked at $94K in Q2 2020. 44 funds tracked by Wall St. Rank hold LJPC as of Q4 2021.

  • SignatureFD reported no remaining La Jolla Pharmaceutical Company position as of Q4 2021 after selling out during the quarter.
  • SignatureFD sold 10,000 La Jolla Pharmaceutical Company shares in Q4 2021, an estimated $40K.
  • SignatureFD first reported a position in La Jolla Pharmaceutical Company in Q2 2020 and held it in 6 quarters.
  • SignatureFD's La Jolla Pharmaceutical Company position peaked at $94K in Q2 2020.
  • 44 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2021.

Based on SignatureFD's 13F filing for Q4 2021, filed 25 Jan 2022.